CFTR and cystic fibrosis: For example, results from a large randomised trial including children and adults with CF indicated that the mean absolute improvement in the percentage of FEV1%predicted ranged from 2.6 to 4.0% with the use of a CFTR corrector (lumacaftor) in combination with a potentiator (ivacaftor) [37].